SMTL ID : 2rl5.1

Crystal structure of the VEGFR2 kinase domain in complex with a 2,3-dihydro-1,4-benzoxazine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

monomer

Ligands

1 x 2RL: N-(4-CHLOROPHENYL)-7-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]-2,3-DIHYDRO-1,4-BENZOXAZINE-4-CARBOXAMIDE(Non-covalent)

2RL.1: 19 residues within 4Å: Chain A: L.26, V.34, A.52, K.54, E.71, L.75, I.78, V.85, T.102, E.103, F.104, C.105, K.106, G.108, L.155, L.171, C.181, D.182, F.183 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.34, A:A.52, A:L.75, A:F.104, A:L.171, A:D.182, A:F.183 Hydrogen bonds: A:E.71, A:C.105, A:D.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

La, D.S. et al., Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis. J.Med.Chem. (2008)

Release Date

2008-04-08

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence